Position in AZN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,506,207
-$155,276 QoQ
Shares Held
13,217
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#117
of 567 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $26,573,081 across 16 Drug Manufacturers - General names. AZN ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,036 | $6,040,329 | |
| 2 | MRK |
Merck & Co., Inc.
|
44,957 | $5,776,974 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
30,848 | $3,897,336 | |
| 4 | AMGN |
Amgen Inc
|
10,266 | $3,717,523 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
13,217 | $2,506,207 | |
| 6 | ABBV |
AbbVie Inc.
|
5,759 | $1,449,194 | |
| 7 | NVS |
Novartis AG
|
7,794 | $1,221,475 | |
| 8 | JNJ |
Johnson & Johnson
|
3,962 | $1,006,229 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,506,207 | 13,217 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,661,483 | 13,495 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||